| Product |
CAS |
Molecular formula |
More |
| Methyl 4-amino-6-chloropicolinate |
1235475-17-8 |
C7H7ClN2O2 |
More |
| 4-Bromo-6-chloropicolinic acid |
1060805-66-4 |
C6H3BrClNO2 |
More |
| (R)-4-chloro-diphenylmethanol |
123535-85-3 |
C13H11ClO |
More |
| (S)-4-chloro-diphenylmethanol |
101402-04-4 |
C13H11ClO |
More |
| Ezetimibe intermediates |
852148-49-3 |
C21H22FNO4 |
More |
| Peramivir intermediates |
77745-25-6 |
C7H11NO2.HCl |
More |
| (R)-2-chloro-diphenylmethanol |
16071-26-4 |
C13H11ClO |
More |
| (R)-(+)-p-chloro-n-acetyl-1-methylbenzylamine |
186296-21-9 |
C10H12ClNO |
More |
| Rosuvastatin or pitavastatin side-chain |
124952-23-4 |
|
More |
| Imatinib |
152459-95-9 |
|
More |
| Lacosamide intermediate |
180060-98-4 |
|
More |
| Lacosamide intermediate |
196601-68-0 |
C19H22N2O4 |
More |
| Moxifloxacin ep impurity a |
151213-15-9 |
C20H21F2N3O3 |
More |
| Moxifloxacin ep impurity b |
1029364-73-5 |
C22H27N3O5 |
More |
| Moxifloxacin optical enantiomer |
268545-13-7 |
C21H24FN3O4 |
More |
| Lansoprazole ep impurity a |
953787-54-7 |
C16H14F3N3O4S |
More |
| Lansoprazole ep impurity b |
131926-99-3 |
C16H14F3N3O3S |
More |
| Esomeprazole ep imuprity d |
88546-55-8 |
C17H19N3O4S |
More |
| Esomeprazole ep imuprity e |
176219-04-8 |
C17H19N3O4S |
More |
| Fluconazole ep impurity b |
871550-15-1 |
C15H14FN9O |
More |
